Title : Development and validation of New Analytical methods for Citalopram hydrobromide, Lomustine, Retigabine and Topiramate using Chromatographic Techniques

Type of Material: Thesis
Title: Development and validation of New Analytical methods for Citalopram hydrobromide, Lomustine, Retigabine and Topiramate using Chromatographic Techniques
Researcher: Kanuparthy, Rama Seshaiah
Guide: Reddy, V Ranga
Mukkanti, K.
Department: Department of Chemistry
Publisher: Jawaharlal Nehru Technological University, Hyderabad
Place: Hyderabad
Year: 2013
Language: English
Subject: Analytical
Chromatographic
Development
Techniques
Topiramate
Dissertation/Thesis Note: PhD; Department of Chemistry, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad; 2013
Fulltext: Shodhganga

00000000ntm a2200000ua 4500
001454002
003IN-AhILN
0052024-07-12 16:56:36
008__240712t2013||||ii#||||g|m||||||||||eng||
035__|a(IN-AhILN)th_454002
040__|aJNTU_500028|dIN-AhILN
041__|aeng
100__|aKanuparthy, Rama Seshaiah|eResearcher
110__|aDepartment of Chemistry|bJawaharlal Nehru Technological University, Hyderabad|dHyderabad|ein|0U-0017
245__|aDevelopment and validation of New Analytical methods for Citalopram hydrobromide, Lomustine, Retigabine and Topiramate using Chromatographic Techniques
260__|aHyderabad|bJawaharlal Nehru Technological University, Hyderabad|c2013
300__|a284 p.|dNone|c-
500__|aReferences p. 280-284
502__|cDepartment of Chemistry, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad|d2013|bPhD
520__|aThe thesis entitled Synthesis, Characterization and Biological Activity newlineof NSAIDs Derived Esters, Imides and Pyrazolines comprises of five newlinechapters. newlineCHAPTER-1 newlineA brief review on pharmacological activities of non steroidal anti-newlineinflammatory drugs (NSAIDs) and their derivatives. This chapter deals with general survey of the relevant literature related to newlinethe present topic which describes the development of pharmacologically newlineimportant derivatives of non steroidal anti-inflammatory drugs (NSAIDs) as new scaffold by minimizing the toxic effects of existing agents. Several strategies have been reported on the modification of the well known NSAIDs for the design and development of new scaffold, such as novel cyclooxygenase-2 (COX-2) inhibitors, nitric oxide donors, prodrugs, antioxidants, antibacterial and cytotoxic agents.Therefore, it may be feasible to develop safer and more efficacious drugs by modifying NSAIDs.
653__|aAnalytical
653__|aChromatographic
653__|aDevelopment
653__|aTechniques
653__|aTopiramate
700__|aReddy, V Ranga|eGuide
700__|aMukkanti, K.|eCo-Guide
856__|uhttp://shodhganga.inflibnet.ac.in/handle/10603/19766|yShodhganga
905__|afromsg

User Feedback Comes Under This section.